BHV-7000 Epilepsy Enrollment Paused After FDA Partial Hold
The FDA placed a partial clinical hold on Biohaven’s BHV-7000 epilepsy program after requesting more information about a specific metabolite observed in rodent testing. New enrollment is paused in the ongoing epilepsy studies, while…
